UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Ras‐MEK‐ERK signaling cascade regulates androgen receptor element‐inducible gene transcription and DNA synthesis in prostate cancer cells

International journal of cancer, 2007-08, Vol.121 (3), p.520-527

2007

Link zum Volltext

Verfügbarkeit prüfen

Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: Roles of ERK/MAP kinase

The Prostate, 2009-06, Vol.69 (9), p.949-955

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer

The Journal of pathology, 2009-08, Vol.218 (4), p.514-519

2009

Link zum Volltext

Verfügbarkeit prüfen

Mutations of BRAF and RAS are rare events in germ cell tumours

International journal of cancer, 2005-01, Vol.113 (2), p.329-335

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2014, Vol.20 (1), p.233-245

2014

Link zum Volltext

Verfügbarkeit prüfen

Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation

International journal of cancer, 2013-04, Vol.132 (7), p.1537-1546

2013

Link zum Volltext

Verfügbarkeit prüfen

Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11613-11621

2005

Link zum Volltext

Verfügbarkeit prüfen

Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro

Anticancer research, 2012-05, Vol.32 (5), p.1627-1637

2012

Link zum Volltext

Verfügbarkeit prüfen

BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma

Clinical cancer research, 2014-05, Vol.20 (9), p.2410-2423

2014

Link zum Volltext

Verfügbarkeit prüfen

Bombesin regulates cyclin D1 expression through the early growth response protein egr-1 in prostate cancer cells

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.9934-9942

2005

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the BRAF gene in ulcerative colitis‐related colorectal carcinoma

International journal of cancer, 2005-07, Vol.115 (5), p.673-677

2005

Link zum Volltext

Verfügbarkeit prüfen

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells

British journal of haematology, 2009-01, Vol.144 (1), p.41-52

2009

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (6), p.2461-2470

2009

Link zum Volltext

Verfügbarkeit prüfen

Leucine‐zipper protein, LDOC1, inhibits NF‐κB activation and sensitizes pancreatic cancer cells to apoptosis

International journal of cancer, 2003-07, Vol.105 (4), p.454-458

2003

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

British journal of cancer, 2013-05, Vol.108 (9), p.1862-1869

2013

Link zum Volltext

Verfügbarkeit prüfen

Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells

The Prostate, 2004-05, Vol.59 (2), p.214-225

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer

Breast cancer research and treatment, 2005-09, Vol.93 (1), p.67-74

2005

Link zum Volltext

Verfügbarkeit prüfen

Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 mice

International journal of cancer, 2005-01, Vol.113 (3), p.423-433

2005

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer Treatment

2015, 2015

Link zum Volltext

Verfügbarkeit prüfen

Combination of targeted therapy and immunotherapy in melanoma

Cancer Immunology, Immunotherapy, 2011-10, Vol.60 (10), p.1359-1371

2011

Link zum Volltext

Verfügbarkeit prüfen

The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells

Breast cancer research and treatment, 2011-09, Vol.129 (2), p.387-400

2011

Link zum Volltext

Verfügbarkeit prüfen

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

Cancer Immunology, Immunotherapy, 2005-04, Vol.54 (4), p.307-314

2005

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants in fas signaling pathway genes and risk of gastric cancer

International journal of cancer, 2014-02, Vol.134 (4), p.822-831

2014

Link zum Volltext

Verfügbarkeit prüfen

KLF4‐dependent, PPARγ‐induced expression of GPA33 in colon cancer cell lines

International journal of cancer, 2009-12, Vol.125 (12), p.2802-2809

2009

Link zum Volltext

Verfügbarkeit prüfen

Annexin 1: Differential expression in tumor and mast cells in human larynx cancer

International journal of cancer, 2007-06, Vol.120 (12), p.2582-2589

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaMice

ThemaMedical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)
Bücher
(1)

Sprache

Englisch
(54)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(53)
Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(49)
Tumors
(44)
Female
(26)
Male
(24)
Aged
(20)
Middle Aged
(20)
Adult
(16)
Gynecology. Andrology. Obstetrics
(16)
Gastroenterology. Liver. Pancreas. Abdomen
(14)
Cancer Research
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(11)
Antineoplastic Agents
(10)
Breast Cancer
(10)
Cell Line, Tumor
(10)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ras‐MEK‐ERK signaling cascade regulates androgen receptor element‐inducible gene transcription and DNA synthesis in prostate cancer cells

Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: Roles of ERK/MAP kinase

Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer

Mutations of BRAF and RAS are rare events in germ cell tumours

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation

Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway

Metformin and the mTOR Inhibitor Everolimus (RAD001) Sensitize Breast Cancer Cells to the Cytotoxic Effect of Chemotherapeutic Drugs In Vitro

BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma

Bombesin regulates cyclin D1 expression through the early growth response protein egr-1 in prostate cancer cells

Mutations of the BRAF gene in ulcerative colitis‐related colorectal carcinoma

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells

Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Leucine‐zipper protein, LDOC1, inhibits NF‐κB activation and sensitizes pancreatic cancer cells to apoptosis

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer

Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 mice

Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer Treatment

Combination of targeted therapy and immunotherapy in melanoma

The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

Genetic variants in fas signaling pathway genes and risk of gastric cancer

KLF4‐dependent, PPARγ‐induced expression of GPA33 in colon cancer cell lines

Annexin 1: Differential expression in tumor and mast cells in human larynx cancer

Aktive Filter

Suchergebnisse filtern